Lineage Cell Therapeutics logo
Lineage Cell Therapeutics LCTX
$ 1.48 -1.99%

Annual report 2025
added 03-05-2026

report update icon

Lineage Cell Therapeutics DPO Ratio 2011-2026 | LCTX

Annual DPO Ratio Lineage Cell Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - 1.21 K 1.49 K 788 2.48 K 2.15 K 2.85 K 2.04 K 1.62 K 923 1 K 1.79 K 982 -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
2.85 K 788 1.61 K

Quarterly DPO Ratio Lineage Cell Therapeutics

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - 4.02 K - 4.79 K 4.77 K 1.98 K - 1.25 K 1.86 K 2.07 K - 1.06 K 1.18 K 1.68 K - 286 2.01 K 2.2 K - 2.34 K 3.18 K 2.45 K - 1.94 K 2.07 K 3.21 K - 6.15 K 2.03 K 1.38 K - 1.65 K 17.1 K 2.03 K - 2.51 K 1.53 K 890 - 591 982 881 - 907 832 1.98 K - 1.72 K 1.96 K 1.26 K - 628 1.27 K 5.15 K - 5.51 K 2.06 K -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
17.1 K 286 2.51 K

DPO Ratio of other stocks in the Biotechnology industry

Issuer DPO Ratio Price % 24h Market Cap Country
Acorda Therapeutics Acorda Therapeutics
ACOR
277 - -24.86 % $ 820 K usaUSA
I-Mab I-Mab
IMAB
2.24 K - - $ 866 M chinaChina
Akebia Therapeutics Akebia Therapeutics
AKBA
168 $ 1.4 -0.71 % $ 360 M usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
78.2 - - $ 40.3 B usaUSA
Aytu BioScience Aytu BioScience
AYTU
186 $ 2.55 -0.78 % $ 16 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
162 - -18.52 % $ 27.3 M britainBritain
AstraZeneca PLC AstraZeneca PLC
AZN
265 - - $ 96.9 B britainBritain
Advaxis Advaxis
ADXS
143 K - -9.65 % $ 45.9 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
31.7 $ 20.37 -2.4 % $ 952 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
395 $ 4.08 -2.16 % $ 436 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
2.21 K - - $ 7.46 M israelIsrael
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
115 - - - russiaRussia
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
133 $ 24.21 -1.47 % $ 3.08 B usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
915 - 0.49 % $ 251 B cayman-islandsCayman-islands
Aeterna Zentaris Aeterna Zentaris
AEZS
34.4 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
9.04 K - -10.17 % $ 12.2 K usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
4.06 K $ 32.24 -4.1 % $ 2.14 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
1.92 - 1.93 % $ 17.4 M usaUSA
Avid Bioservices Avid Bioservices
CDMO
62.3 - - $ 789 M usaUSA